Carregant...
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
BACKGROUND AND OBJECTIVE: As new migraine prevention treatments are developed, the onset of a preventive effect, how long it is maintained and whether patients initially non-responsive develop clinically meaningful responses with continued treatment can be assessed. METHODS: Analyses were conducted...
Guardat en:
| Publicat a: | J Neurol Neurosurg Psychiatry |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691875/ https://ncbi.nlm.nih.gov/pubmed/31004075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2018-320242 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|